Search all medical codes

Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision

HCPCS code

Screening Cytopathology, Cervical or Vaginal (G0123)

Name of the Procedure:

  • Common Name: Pap Smear, Pap Test
  • Technical/Medical Terms: Screening Cytopathology, Cervical or Vaginal, Collected in Preservative Fluid, Automated Thin Layer Preparation, Screening by Cytotechnologist under Physician Supervision

Summary

A Pap smear is a medical test that screens for cervical and vaginal cancers or pre-cancerous conditions. During the test, cells are collected from the cervix or vagina and then preserved in a fluid. These cells are then analyzed using an automated thin layer preparation method, first by a cytotechnologist and then under the supervision of a physician.

Purpose

The primary goal of the Pap smear is to detect abnormal cells in the cervix or vagina that may indicate cancer or pre-cancerous conditions. Early detection can lead to earlier treatment and better outcomes.

Indications

  • Routine screening as part of regular gynecological exams.
  • Women aged 21-65, following guidelines for the frequency of screening.
  • Women with symptoms such as unexplained bleeding, discharge, or pain.

Preparation

  • Avoid intercourse, douching, or using vaginal medications for at least 48 hours before the test.
  • Schedule the test for at least a week after the end of menstrual period.
  • No extensive fasting or significant medication adjustments are usually required.

Procedure Description

  1. Collection:

    • The patient lies on an exam table and a speculum is inserted into the vagina to provide access to the cervix.
    • A brush or spatula is used to gently collect cells from the cervix.
  2. Preservation:

    • The collected cells are placed in a preservative fluid to maintain their integrity.
  3. Preparation and Screening:

    • An automated thin layer preparation method is used to create a uniform sample on a microscope slide.
    • Cytotechnologists first screen the slide for abnormalities under physician supervision.

Duration

The entire procedure takes about 5-10 minutes.

Setting

  • Typically performed in an outpatient clinic, gynecologist's office, or primary care setting.

Personnel

  • Gynecologist or trained healthcare provider for cell collection.
  • Cytotechnologist for initial screening.
  • Physician for supervision and final review.

Risks and Complications

  • Minor discomfort or spotting following the procedure.
  • Rare risk of infection.
  • False-negative or false-positive results, leading to further testing.

Benefits

  • Early detection of cervical or vaginal cancer or pre-cancerous conditions.
  • Increased chances of a successful treatment and better health outcomes.
  • Usually can expect results within a few days to a week.

Recovery

  • No significant recovery time required.
  • Patients can return to normal activities immediately after the test.
  • Follow up with the healthcare provider to discuss results and further steps if necessary.

Alternatives

  • HPV Testing: Can be done in conjunction with or instead of a Pap smear, especially in older women.
  • Visual Inspection with Acetic Acid (VIA): Used in low-resource settings.

Patient Experience

  • Mild discomfort or light cramping during cell collection.
  • Minor bleeding or spotting may occur.
  • Any significant pain or prolonged symptoms should be reported to the healthcare provider for evaluation.
  • Healthcare providers offer comfort measures and reassurance throughout the procedure.

Medical Policies and Guidelines for Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision

Related policies from health plans

Similar Codes